Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 4.785
+0.085 (1.81%)
Sep 14, 2026, 1:14 PM CET
Thor Medical ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 59.9 | 180.56 | 123.39 | 41.77 | 98.72 |
Cash & Short-Term Investments | 59.9 | 180.56 | 123.39 | 41.77 | 98.72 |
Cash Growth | -73.31% | 46.33% | 195.42% | -57.69% | - |
Accounts Receivable | 0.5 | 0.3 | - | - | - |
Other Receivables | 15.1 | 13.96 | 5.88 | 2.9 | 3.18 |
Receivables | 15.6 | 14.25 | 5.88 | 2.9 | 3.18 |
Inventory | 42.3 | 2.96 | - | - | - |
Prepaid Expenses | - | 1.67 | 0.58 | 0.43 | 0.88 |
Other Current Assets | - | 0.07 | 0.07 | 0.25 | 6.34 |
Total Current Assets | 117.8 | 199.51 | 129.91 | 45.35 | 109.11 |
Property, Plant & Equipment | 350.9 | 244.23 | 1.43 | 1.01 | 0.54 |
Goodwill | - | 37.22 | 37.22 | 37.22 | - |
Other Intangible Assets | 254.7 | 226.93 | 245.82 | 247.27 | - |
Other Long-Term Assets | 0.7 | 0.76 | - | - | - |
Total Assets | 724.1 | 708.64 | 414.38 | 330.84 | 109.65 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 17.3 | 14.85 | 15.23 | 2.1 | 9.09 |
Accrued Expenses | 1 | 16.63 | 7.23 | 1.49 | 4.92 |
Current Portion of Leases | 14.6 | 12.18 | 0.44 | - | 0.16 |
Current Income Taxes Payable | - | - | - | - | 0.76 |
Other Current Liabilities | 5.9 | - | -0 | 0.85 | 29.36 |
Total Current Liabilities | 40.8 | 43.66 | 22.9 | 4.45 | 44.28 |
Long-Term Leases | 167.5 | 159.2 | 0.3 | - | - |
Pension & Post-Retirement Benefits | - | - | - | - | 1.52 |
Long-Term Deferred Tax Liabilities | 47.6 | 49.78 | 54.03 | 54.46 | - |
Total Liabilities | 314 | 252.64 | 77.23 | 58.91 | 45.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 72 | 70.82 | 56.1 | 46.71 | 23.21 |
Additional Paid-In Capital | 513.8 | 506.26 | 344.11 | 246.07 | 66.55 |
Retained Earnings | -175.8 | -121.07 | -63.06 | -20.85 | -28.43 |
Comprehensive Income & Other | 0.1 | - | - | - | 2.51 |
Shareholders' Equity | 410.1 | 456 | 337.14 | 271.93 | 63.84 |
Total Liabilities & Equity | 724.1 | 708.64 | 414.38 | 330.84 | 109.65 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 242.2 | 171.38 | 0.74 | - | 0.16 |
Net Cash (Debt) | -182.3 | 9.18 | 122.65 | 41.77 | 98.56 |
Net Cash Growth | - | -92.52% | 193.66% | -57.62% | - |
Net Cash Per Share | -0.51 | 0.03 | 0.52 | 0.24 | 0.86 |
Filing Date Shares Outstanding | 360 | 354.08 | 314.41 | 233.54 | 115.13 |
Total Common Shares Outstanding | 360 | 354.08 | 280.49 | 233.54 | 115.13 |
Working Capital | 77 | 155.86 | 107.01 | 40.9 | 64.83 |
Book Value Per Share | 1.14 | 1.29 | 1.20 | 1.16 | 0.55 |
Tangible Book Value | 155.4 | 191.86 | 54.11 | -12.56 | 63.84 |
Tangible Book Value Per Share | 0.43 | 0.54 | 0.19 | -0.05 | 0.55 |
Buildings | 3.7 | 3.81 | - | - | - |
Machinery | 7.1 | 6.9 | 4.93 | 4.93 | 10.85 |
Construction In Progress | 169.4 | 67.26 | - | - | - |
Order Backlog | - | 850 | - | - | - |